GlobeNewswire: Galen Partners Contains the last 10 of 5 releaseshttp://www.globenewswire.com/External?Length=42024-03-28T12:48:33ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2020/01/08/1967799/0/en/Galen-Partners-completes-acquisition-of-Evolve-Treatment-Centers-a-leading-provider-of-adolescent-behavioral-health-services-in-California.html?f=22&fvtc=4&fvtv=35784Galen Partners completes acquisition of Evolve Treatment Centers, a leading provider of adolescent behavioral health services in California2020-01-08T13:00:00Z<![CDATA[STAMFORD, Conn., Jan. 08, 2020 (GLOBE NEWSWIRE) -- Galen Partners, a healthcare-focused growth equity investment firm, announced today the acquisition of Evolve Treatment Centers. Headquartered in Los Angeles, CA, Evolve is a leading adolescent behavioral health services provider, specializing in mental health, trauma, and substance abuse for adolescents in need. Evolve’s mission is to transform the teen mental health space, ensuring that teens and their families have the highest level of compassionate care available.]]>https://www.globenewswire.com/news-release/2019/10/24/1934965/0/en/Galen-Partners-completes-add-on-acquisition-for-SMP-Pharmacy-Solutions-a-niche-focused-high-touch-specialty-pharmacy.html?f=22&fvtc=4&fvtv=35784Galen Partners completes add-on acquisition for SMP Pharmacy Solutions, a niche-focused, high-touch specialty pharmacy2019-10-24T12:30:00Z<![CDATA[The addition of Northridge Plaza Pharmacy will enable SMP to meet the growing demand across California’s robust fertility market]]>https://www.globenewswire.com/news-release/2018/07/19/1539530/0/en/Galen-Partners-completes-investment-in-SMP-Pharmacy-Solutions-a-niche-focused-high-touch-specialty-pharmacy.html?f=22&fvtc=4&fvtv=35784Galen Partners completes investment in SMP Pharmacy Solutions, a niche-focused, high-touch specialty pharmacy2018-07-19T12:30:00Z<![CDATA[Galen teams with SMP’s Founder / CEO and existing management to recapitalize the company]]>https://www.globenewswire.com/news-release/2017/11/10/1184582/0/en/Galen-Partners-Completes-Sale-of-Cambrooke-Therapeutics.html?f=22&fvtc=4&fvtv=35784Galen Partners Completes Sale of Cambrooke Therapeutics2017-11-10T13:00:00Z<![CDATA[STAMFORD, Conn., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Galen Partners, a healthcare-focused, growth equity investment firm, announced today the sale of Cambrooke Therapeutics, Inc. (“Cambrooke”) to Ajinomoto Co.]]>https://www.globenewswire.com/news-release/2017/07/11/1042416/0/en/Galen-Partners-Completes-Majority-Recapitalization-of-CDx-Diagnostics.html?f=22&fvtc=4&fvtv=35784Galen Partners Completes Majority Recapitalization of CDx Diagnostics2017-07-11T12:00:00Z<![CDATA[Leading healthcare-focused growth equity firm and operating partners collaborate with existing management to acquire a proprietary cancer diagnostics company Leading healthcare-focused growth equity firm and operating partners collaborate with existing management to acquire a proprietary cancer diagnostics company]]>